SCHEMBL3041200

SCHEMBL3041200

OCc1c(OC(=S)Cc2ccccc2)ccc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCEH1 Q6PIU2 4/20 0.41
▸ KMT2A Q03164 5/20 0.39
▸ POLB P06746 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ WDR77 Q9BQA1 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3041196 0.78 TDP1 (0.35) NCEH1GAAKDM4EHPGDL3MBTL1
SCHEMBL29620186 0.72 MAPT (0.58) KMT2APOLBSMN1; SMN2MEN1HTT
SCHEMBL702988 0.72 MAPT (0.58) KMT2APOLBSMN1; SMN2MEN1HTT
SCHEMBL10345808 0.69 ALOX5 (0.51) KMT2APOLBALDH1A1GAASMN1; SMN2
SCHEMBL15414250 0.69 ALOX5 (0.51) NCEH1KMT2AALDH1A1NPSR1HSD17B10
SCHEMBL15564688 0.68 PRMT5 (0.41) NCEH1KMT2AALDH1A1GAAMEN1
SCHEMBL15414084 0.68 MAPT (0.54) NCEH1KMT2AALDH1A1GAAMEN1
SCHEMBL3041847 0.67 ALDH1A1 (0.49) NCEH1KMT2APOLBALDH1A1SMN1; SMN2
SCHEMBL10456727 0.67 PRMT5 (0.46) KMT2AALDH1A1GAASMN1; SMN2MEN1
SCHEMBL313000 0.66 MAPT (0.49) NCEH1KMT2APOLBSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8647878-B2 Highly refractive immersion liquids and their use CARL ZEISS AG (DE) 2014-02-11 — — US disclosed
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use CARL ZEISS AG (DE) 2010-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use NR4A3, NR2E3, NR4A1 NCEH1 1797/4885KMT2A 3367/4885POLB 3554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback